Interpretable survival prediction for colorectal cancer using deep learning

Deriving interpretable prognostic features from deep-learning-based prognostic histopathology models remains a challenge. In this study, we developed a deep learning system (DLS) for predicting disease specific survival for stage II and III colorectal cancer using 3,652 cases (27,300 slides). When evaluated on two validation datasets containing 1,239 cases (9,340 slides) and 738 cases (7,140 slides) respectively, the DLS achieved a 5-year disease-specific survival AUC of 0.70 (95%CI 0.66-0.73) and 0.69 (95%CI 0.64-0.72), and added significant predictive value to a set of 9 clinicopathologic features. To interpret the DLS, we explored the ability of different human-interpretable features to explain the variance in DLS scores. We observed that clinicopathologic features such as T-category, N-category, and grade explained a small fraction of the variance in DLS scores (R2=18% in both validation sets). Next, we generated human-interpretable histologic features by clustering embeddings from a deep-learning based image-similarity model and showed that they explain the majority of the variance (R2 of 73% to 80%). Furthermore, the clustering-derived feature most strongly associated with high DLS scores was also highly prognostic in isolation. With a distinct visual appearance (poorly differentiated tumor cell clusters adjacent to adipose tissue), this feature was identified by annotators with 87.0-95.5% accuracy. Our approach can be used to explain predictions from a prognostic deep learning model and uncover potentially-novel prognostic features that can be reliably identified by people for future validation studies.

[1]  Ellery Wulczyn,et al.  Deep learning-based survival prediction for multiple cancer types using histopathology images , 2019, PloS one.

[2]  T R Fleming,et al.  Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Andrew H. Beck,et al.  Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival , 2011, Science Translational Medicine.

[4]  Joseph Kannarkatt,et al.  Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma. , 2017, Journal of oncology practice.

[5]  S. Kakar,et al.  Tumor Budding in Colorectal Carcinoma: Translating a Morphologic Score Into Clinically Meaningful Results. , 2018, Archives of pathology & laboratory medicine.

[6]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[7]  Zlatko Trajanoski,et al.  In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Mithat Gönen,et al.  Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology–molecular associations: clinical and biological implications , 2017, Modern Pathology.

[9]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[10]  T. Schaller,et al.  Interobserver variability in the H&E-based assessment of tumor budding in pT3/4 colon cancer: does it affect the prognostic relevance? , 2018, Virchows Archiv.

[11]  D. Berger,et al.  Perineural invasion is an independent predictor of outcome in colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Mukesh G Harisinghani,et al.  Bowel wall fat halo sign in patients without intestinal disease. , 2003, AJR. American journal of roentgenology.

[13]  G. Wainrib,et al.  Deep learning-based classification of mesothelioma improves prediction of patient outcome , 2019, Nature Medicine.

[14]  Giacomo Puppa,et al.  TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. , 2010, Archives of pathology & laboratory medicine.

[15]  M. Washington,et al.  Lymphovascular Invasion in Colorectal Cancer: An Interobserver Variability Study , 2008, The American journal of surgical pathology.

[16]  H. Denk,et al.  Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer , 2004, Virchows Archiv.

[17]  Marco Novelli,et al.  Deep learning for prediction of colorectal cancer outcome: a discovery and validation study , 2020, The Lancet.

[18]  N. Petrelli,et al.  Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Sergey Ioffe,et al.  Rethinking the Inception Architecture for Computer Vision , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[20]  Paolo Bechi,et al.  Character of the invasive margin in colorectal cancer , 1997, Diseases of the colon and rectum.

[21]  Eisaku Ito,et al.  Desmoplastic Pattern at the Tumor Front Defines Poor-prognosis Subtypes of Colorectal Cancer , 2017, The American journal of surgical pathology.

[22]  George E. Dahl,et al.  Artificial Intelligence-Based Breast Cancer Nodal Metastasis Detection: Insights Into the Black Box for Pathologists. , 2018, Archives of pathology & laboratory medicine.

[23]  Hideki Ueno,et al.  Histologic Categorization of Desmoplastic Reaction: Its Relevance to the Colorectal Cancer Microenvironment and Prognosis , 2015, Annals of Surgical Oncology.

[24]  Randy Goebel,et al.  Towards Integrative Machine Learning and Knowledge Extraction , 2015, BIRS-IMLKE.

[25]  D.,et al.  Regression Models and Life-Tables , 2022 .

[26]  Viktor H. Koelzer,et al.  The Tumor Border Configuration of Colorectal Cancer as a Histomorphological Prognostic Indicator , 2014, Front. Oncol..

[27]  Andreas Holzinger,et al.  NLP for the Generation of Training Data Sets for Ontology-Guided Weakly-Supervised Machine Learning in Digital Pathology , 2019, 2019 IEEE Symposium on Computers and Communications (ISCC).

[28]  A. Madabhushi,et al.  Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers , 2018, Laboratory Investigation.

[29]  Constantino Carlos Reyes-Aldasoro,et al.  Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study , 2019, PLoS medicine.

[30]  A. Madabhushi,et al.  Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology , 2019, Nature Reviews Clinical Oncology.

[31]  Cord Langner,et al.  Cancer Management and Research Dovepress Prognostic Stratification of Colorectal Cancer Patients: Current Perspectives , 2022 .

[32]  Bo Chen,et al.  MobileNets: Efficient Convolutional Neural Networks for Mobile Vision Applications , 2017, ArXiv.

[33]  Ce Zhang,et al.  Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features , 2016, Nature Communications.

[34]  Dmitrii Bychkov,et al.  Deep learning based tissue analysis predicts outcome in colorectal cancer , 2018, Scientific Reports.

[35]  Mithat Gonen,et al.  Individualized prediction of colon cancer recurrence using a nomogram. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Andrew Zisserman,et al.  Deep Inside Convolutional Networks: Visualising Image Classification Models and Saliency Maps , 2013, ICLR.

[37]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[38]  F. Marincola,et al.  International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study , 2018, The Lancet.

[39]  F. Harrell,et al.  Evaluating the yield of medical tests. , 1982, JAMA.

[40]  Jun Akatsuka,et al.  Automated acquisition of explainable knowledge from unannotated histopathology images , 2019, Nature Communications.

[41]  F M Corl,et al.  CT evaluation of the colon: inflammatory disease. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[42]  B. Huppertz,et al.  Biobank Graz: The Hub for Innovative Biomedical Research , 2016 .

[43]  Neofytos Dimitriou,et al.  A principled machine learning framework improves accuracy of stage II colorectal cancer prognosis , 2018, npj Digital Medicine.

[44]  Franck Bonnetain,et al.  Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer , 2009, Gut.

[45]  Jimmy Ba,et al.  Adam: A Method for Stochastic Optimization , 2014, ICLR.

[46]  Anne E Carpenter,et al.  Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software , 2011, Bioinform..

[47]  Dominique Scherer,et al.  Signals from the Adipose Microenvironment and the Obesity–Cancer Link—A Systematic Review , 2017, Cancer Prevention Research.

[48]  Zhen Li,et al.  Graph-RISE: Graph-Regularized Image Semantic Embedding , 2019, ArXiv.

[49]  Daniel Smilkov,et al.  Similar image search for histopathology: SMILY , 2019, npj Digital Medicine.

[50]  Yoshua Bengio,et al.  Random Search for Hyper-Parameter Optimization , 2012, J. Mach. Learn. Res..

[51]  N. Breslow Covariance analysis of censored survival data. , 1974, Biometrics.

[52]  Yuan Yuan Wang,et al.  Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. , 2011, Cancer research.

[53]  D. Brat,et al.  Predicting cancer outcomes from histology and genomics using convolutional networks , 2017, Proceedings of the National Academy of Sciences.

[54]  D. Kerr,et al.  Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study , 2007, The Lancet.

[55]  C. Ko,et al.  Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. , 2005, Journal of the National Cancer Institute.